September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference ...
September 13, 2017 — A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results ...
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, according ...
September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in ...
September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...
September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...
September 12, 2017 – The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as ...
September 11, 2017 — Researchers have led a retrospective single-center study examining simple hemodynamic parameters ...
September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular ...
September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late ...
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of ...
September 7, 2017 — Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System ...
September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and Xience dr ...
September 13, 2017